Phase 3 Trials
(Search results - 1)IndiaMar 3, 2021, 7:19 PM IST
Covaxin enjoys 81% efficacy after phase 3 trials
Bharat Biotech’s vaccine – Covaxin – enjoys clinical success of 81% after phase 3 trials
IndiaMar 3, 2021, 7:19 PM IST
Bharat Biotech’s vaccine – Covaxin – enjoys clinical success of 81% after phase 3 trials